other material
confidence high
sentiment neutral
materiality 0.20
Veracyte registers 1.68M shares for resale related to C2i Genomics acquisition
VERACYTE, INC.
- Filed prospectus supplement to register up to 1,681,384 shares of common stock for resale.
- Shares were issued in connection with the acquisition of C2i Genomics, Inc. on Feb 5, 2024.
- Includes opinion of counsel (Fenwick & West) on legality of the shares.
- This is a procedural step; no new financial or operational information.